Share on StockTwits

Mindray Medical International Ltd (NYSE:MR) issued its quarterly earnings data on Monday. The company reported $0.56 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.54 by $0.02, Analyst Ratings Network reports. The company had revenue of $334.50 million for the quarter, compared to the consensus estimate of $348.30 million.

Shares of Mindray Medical International Ltd (NYSE:MR) traded up 2.95% during mid-day trading on Monday, hitting $29.97. The stock had a trading volume of 911,860 shares. Mindray Medical International Ltd has a one year low of $29.02 and a one year high of $43.81. The stock has a 50-day moving average of $30.73 and a 200-day moving average of $32.42. The company has a market cap of $3.502 billion and a P/E ratio of 17.20.

On a related note, analysts at Jefferies Group cut their price target on shares of Mindray Medical International Ltd from $36.00 to $32.00 in a research note on Thursday, May 22nd. They now have a “hold” rating on the stock. Five investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $35.07.

Mindray Medical International Limited (NYSE:MR), is a developer, manufacturer and marketer of medical devices worldwide.

Receive News & Ratings for Mindray Medical International Ltd (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.